Ironwood Pharmaceuticals Inc
F:I76
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ironwood Pharmaceuticals Inc
F:I76
|
US |
|
Hanwa Co Ltd
F:HW4
|
JP |
|
N
|
NICO Resources Ltd
OTC:NICOF
|
AU |
|
A
|
Azenta Inc
F:BA3
|
US |
|
C
|
Corbion NV
F:CSU
|
NL |
|
L
|
Lincoln Gold Mining Inc
XMUN:ZMG
|
CA |
|
F
|
Fujimori Kogyo Co Ltd
F:FJ3
|
JP |
|
A
|
Ag Growth International Inc
F:7AG
|
CA |
|
Science in Sport PLC
F:8D9
|
UK |
|
M
|
MPC Muenchmeyer Petersen Capital AG
SWB:MPCK
|
DE |
|
China Evergrande Group
F:EV1
|
CN |
|
Eisai Co Ltd
OTC:ESALF
|
JP |
|
N
|
New Focus Auto Tech Holdings Ltd
OTC:NWFAF
|
CN |
|
Nevada Copper Corp
F:ZYTA
|
CA |
|
C
|
Cts Eventim AG & Co KgaA
F:EVD
|
DE |
|
Kewpie Corp
OTC:KWPCF
|
JP |
|
H
|
Heron Resources Ltd
F:HR7
|
AU |
|
V
|
Verbio Vereinigte Bioenergie AG
XBER:VBK
|
DE |
|
M
|
Matsui Securities Co Ltd
F:MTW
|
JP |
|
N
|
Nippon Parking Development Co Ltd
F:3SY
|
JP |
|
Kimball Electronics Inc
F:3C3
|
US |
|
C
|
Coppermoly Ltd
F:5C5
|
AU |
|
Infinity Pharmaceuticals Inc
OTC:INFIQ
|
US |
|
S
|
Silver Range Resources Ltd
F:8SR
|
CA |
Wall St Price Targets
I76 Price Targets Summary
Ironwood Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for I76 is 2.13 EUR with a low forecast of 1.23 EUR and a high forecast of 3.8 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I76's stock price target?
Price Target
2.13
EUR
According to Wall Street analysts, the average 1-year price target for I76 is 2.13 EUR with a low forecast of 1.23 EUR and a high forecast of 3.8 EUR.
What is the Revenue forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
-13%
The compound annual growth rate for Operating Income over the next 8 years is -13%.
What is the Pre-Tax Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
67%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 67%.
What is the Net Income forecast for Ironwood Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Net Income over the next 8 years is 7%.
